Scabies pill also works against resistant lice: study

Mar 10, 2010

Ivermectin, a pill prescribed for the skin disease known as scabies, also gets rid of hair lice that are resistant to conventional lotions, a study published on Thursday says.

Lice affects over 100 million people worldwide each year, especially children of primary school age, according to the paper, appearing in the .

The main treatments are diluted forms of an called permethrin and malathion, but since the 1990s have becoming more and more resistant to these chemicals.

That has left parents with little choice other than to be, literally, nit-pickers -- to go through their children's hair with a fine comb to haul out the parasites.

Ivermectin is a promising alternative, say French researchers who led the study.

They tested it in a trial involving 812 adults and children in 376 households in Britain, France, Ireland and Israel.

Half of the patients were treated with malathion and half with ivermectin, which was administered twice, seven days apart, at a dose of 400 microgrammes per kilo (2.2 pounds).

After two weeks, 95.2 percent of the ivermectin group were lice-free, compared with 85 percent in the malathion group.

"Ivermectin is more effective than the best anti-lice lotion, but it should be reserved for difficult, resistant cases," the study's coordinator, Olivier Chosidow of France's National Institute of Health and Medical Research (INSERM), told AFP.

Over-using the drug could make it succumb to resistance, following the same path as the lotions, he said.

Explore further: NIH begins early human clinical trial of VSV Ebola vaccine

add to favorites email to friend print save as pdf

Related Stories

'LouseBuster' Instrument Shown to Kill Head Lice

Nov 06, 2006

Biologists have invented a chemical-free, hairdryer-like device - the LouseBuster - and conducted a study showing it eradicates head lice infestations on children by exterminating the eggs, or "nits," and killing ...

Pubic hair provides evolutionary home for gorilla lice

Feb 11, 2009

There are two species of lice that infest humans: pubic lice, Pthirus pubis, and human head and body lice, Pediculus humanus. A new article in BioMed Central's open access Journal of Biology suggests one explanation for ...

Recommended for you

Added benefit of vedolizumab is not proven

2 hours ago

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0